Literature DB >> 35094494

Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA.

Humberto C Gonzalez1,2, Yueren Zhou3, Faisal M Nimri1, Loralee B Rupp4, Sheri Trudeau3, Stuart C Gordon1,2.   

Abstract

Early reports suggest that alcohol misuse increased in 2020 as a result of the COVID-19 pandemic. Using retrospective data from Henry Ford Health System in Detroit MI-an area that experienced an early and severe COVID-19 outbreak-we investigated the impact of the pandemic on alcohol-related liver disease (ARLD) in the summer of 2020 compared with the same period in 2016-2019. Both the number of ARLD admissions and the proportion of total admissions represented by ARLD patients increased significantly in 2020 compared with previous years. The number of ARLD admissions as a proportion of all hospitalizations was 50% higher in 2020 than in 2016-2019 (0.31% vs 0.21%; P = .0013); by September 2020, the number of admissions was 66% higher than previous years. Despite racial and geographical disparities in direct and indirect COVID-related stressors across the Detroit metropolitan area, the demographic profile of ARLD patients did not change compared with previous years.
© 2022 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SARS-CoV-2; alcohol-related liver disease; alcoholic hepatitis; cirrhosis; hospitalization

Mesh:

Year:  2022        PMID: 35094494     DOI: 10.1111/liv.15172

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  3 in total

1.  Comment on the "The Pandemic Within the Pandemic: Unprecedented Rise in Alcohol-related Hepatitis During the COVID-19 Pandemic".

Authors:  Huifang Xia; Yan Peng; Xiaowei Tang
Journal:  J Clin Gastroenterol       Date:  2022-08-19       Impact factor: 3.174

Review 2.  Covid-19 and alcohol associated liver disease.

Authors:  Sasha Deutsch-Link; Brenda Curtis; Ashwani K Singal
Journal:  Dig Liver Dis       Date:  2022-08-03       Impact factor: 5.165

3.  No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan.

Authors:  Chiara Masetti; Francesca Colapietro; Antonio Voza; Alessio Aghemo
Journal:  Liver Int       Date:  2022-09-06       Impact factor: 8.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.